Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer

BACKGROUND: Clinicopathological and molecular features of responders to nivolumab for advanced gastric cancer (AGC) are not well understood. METHODS: Patients (pts) with AGC who were treated with nivolumab after two or more chemotherapy regimens in a single institution from September 2017 to May 201...

詳細記述

保存先:
書誌詳細
出版年:J Immunother Cancer
主要な著者: Mishima, Saori, Kawazoe, Akihito, Nakamura, Yoshiaki, Sasaki, Akinori, Kotani, Daisuke, Kuboki, Yasutoshi, Bando, Hideaki, Kojima, Takashi, Doi, Toshihiko, Ohtsu, Atsushi, Yoshino, Takayuki, Kuwata, Takeshi, Tsuji, Akihito, Shitara, Kohei
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2019
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357506/
https://ncbi.nlm.nih.gov/pubmed/30704511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0514-3
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料